Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05550740 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Repeated Low-Level Red-Light Therapy for Shortening Axial Length

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 30, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Primary completion date: Mar 1, 2025 to Mar 1, 2026
    • Study completion date: Mar 23, 2025 to Mar 23, 2026
    • Study description expanded, about 2 words
    v4
  3. Primary completion date: Dec 22, 2023 to Mar 1, 2025v3 Show 6 more changesShow less
    • Primary endpoint revised
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study completion date: Dec 22, 2023 to Mar 23, 2025
    • Start date changed from estimate of Oct 22, 2022 to Nov 19, 2022
    • Secondary endpoints revised (9)
    • Study description expanded, about 17 words
  4. Primary and study completion dates: Nov 2023 to Dec 22, 2023
    • Start date: Sep 2022 to Oct 22, 2022
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this clinical trial is to confirm the incidence and magnitude of axial length shortening after RLRL therapy in Chinese high myopia children and teenagers.
Trial Details
NCT Number NCT05550740
Lead Sponsor Shanghai Eye Disease Prevention and Treatment Center
Conditions
(from sponsor)		 High Myopia, Refractive Errors, Eye Diseases
Related terms Eye Diseases, Refractive Errors
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov